Adeno-Associated Virus (AAV) Antibody Study in Subjects OTC Deficiency, GSDIa, and Wilson Disease

Clinical trial NCT04909346 · TERMINATED

Trial details

NCT number: NCT04909346
Sponsor: Ultragenyx Pharmaceutical Inc
Status: TERMINATED
Study type: OBSERVATIONAL

Ornithine Transcarbamylase Deficiency Wilson Disease Glycogen Storage Disease Type IA

Start date: 2021-06-23
Primary completion: 2022-11-17
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.